The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes

Diabetic Medicine

Volumn 23, Issue 7, 2006, Pages 768-774

  Masding, M G ^a,b,c   Stears, A J ^b,c   Burdge, G C ^c   Wootton, S A ^c   Sandeman, D D ^b  

^a POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Lipoproteins; Oestrogens; Postprandial; Type 2 diabetes mellitus

Indexed keywords

CHYLOMICRON; ESTROGEN; PALMITIC ACID C 13; PALMITIC ACID DERIVATIVE; TRIACYLGLYCEROL; TRIPALMITIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; POSTPRANDIAL STATE;

BLOOD GLUCOSE; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMANS; INSULIN; LIPOPROTEINS, HDL; MIDDLE AGED; PALMITIC ACID; POSTMENOPAUSE; POSTPRANDIAL PERIOD; TRIGLYCERIDES;

EID: 33748574281     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01867.x     Document Type: Article

References (22)

1. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham study. Am Heart J 1987; 114: 413-419.
2. Cooper MB, Tan KC, Hales CN, Betteridge DJ. Postprandial lipid metabolism and β-cell function in non-insulin-dependent (Type 2) diabetes mellitus after a mixed meal with a high fat content. Diabet Med 1996; 13: 816-827.
3. Frayn KN. Metabolic characteristics of the organs and tissues. In: Frayn, K ed. Metabolic Regulation: a Human Perspective. London: Portland Press, 1996: 79-80.
4. Jenkins DJ, Wolever TM, Vuksan V, Brighenti F, Cunnane SC, Rao AV et al. Nibbling versus gorging: metabolic advantages of increased meal frequency. N Engl J Med 1989; 321: 929-934.
5. Masding MG, Stears AJ, Burdge GC, Wootton SA, Sandeman DD. Premenopausal advantages in postprandial lipid metabolism are lost in women with type 2 diabetes. Diabetes Care 2003; 26: 3243-3249.
6. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990; 300: 230-235.
7. Berr F, Eckel RH, Kern F Jr. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women. J Lipid Res 1986; 27: 645-651.
8. Westerveld HT, Kock LA, van Rijn HJ, Erkelens DW, de Bruin TW. 17β-Estradiol improves postprandial lipid metabolism in post-menopausal women. J Clin Endo Metab 1995; 80: 249-253.
9. Weintraub M, Grosskopf I, Charach G, Eckstein N, Rubinstein A. Hormone replacement therapy enhances postprandial lipid metabolism in post-menopausal women. Metabolism 1999; 48: 1193-1196.
10. Julius U, Fritsch H, Fritsch W, Rehak E, Fucker K, Leonhardt W et al. Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic post-menopausal women. Clin Invest 1994; 72: 502-507.
11. Lewis GF, O'Meara NM, Soltys PA, Blackman JD, Iverius PH, Pugh WL et al. Fasting hypertriglyceridemia in non-insulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991; 72: 934-944.
12. Szanto A, Balasubramaniam S, Roach PD, Nestel PJ. Modulation of the low-density-lipoprotein-receptor-related protein and its relevance to chylomicron-remnant metabolism. Biochemistry 1992; 288: 791-794.
13. Friday KE, Dong C, Fontenot RU. Conjugated equine estrogen improves glycemic control and blood lipoproteins in post-menopausal women with type 2 diabetes. J Clin Endo Metab 2001; 86: 48-52.
14. Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 1994; 94: 2349-2356.
15. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women. Heart Estrogen/Progestin Replacement Study (HERS) Research Group. J Am Med Assoc 1998; 280: 605-613.
16. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). J Am Med Assoc 2002; 288: 49-57.
17. Robinson JG. How HRT alters the lipid profile in women with diabetes. Medscape 1996; 1: 4-5.
18. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS et al. Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 1987; 65: 181-189.
19. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-1345.
20. Williams CM. Dietary interventions affecting chylomicron and chylomicron remnant clearance. Atherosclerosis 1998; 141: S87-92.
21. Aldred HE, Hardman AE, Taylor S. Influence of 12 weeks of training by brisk walking on postprandial lipemia and insulinemia in sedentary middle-aged women. Metabolism 1995; 44: 390-397.
22. Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ et al. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. Am J Cardiol 2002; 90: 689-696.